News Release

COVID-19 hospitalization in solid organ transplant recipients on immunosuppressive therapy

JAMA Network Open

Peer-Reviewed Publication

JAMA Network

About The Study: The findings of this study suggest that maintenance immunosuppressive drugs are associated with an increased risk of COVID-19 hospitalization in solid organ transplant recipients. These results should be considered by clinicians treating transplant recipients and may help inform epidemic-related decisions for this population in the future.

Authors: Epiphane Kolla, M.D., M.P.H., of French National Health Insurance in Saint-Denis, France, is the corresponding author.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi: 10.1001/jamanetworkopen.2023.42006)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2023.42006?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=110723

About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.